BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32163436)

  • 21. Treatment and vaccination strategies to control cholera in sub-Saharan refugee settings: a cost-effectiveness analysis.
    Naficy A; Rao MR; Paquet C; Antona D; Sorkin A; Clemens JD
    JAMA; 1998 Feb; 279(7):521-5. PubMed ID: 9480362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case-area targeted preventive interventions to interrupt cholera transmission: Current implementation practices and lessons learned.
    Sikder M; Altare C; Doocy S; Trowbridge D; Kaur G; Kaushal N; Lyles E; Lantagne D; Azman AS; Spiegel P
    PLoS Negl Trop Dis; 2021 Dec; 15(12):e0010042. PubMed ID: 34919551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anticholera vaccines and vaccination].
    Ivanoff B; Chaignat CL
    Bull Soc Pathol Exot; 2002 Dec; 95(5):355-8. PubMed ID: 12696375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective cohort study comparing household contact and water Vibrio cholerae isolates in households of cholera patients in rural Bangladesh.
    George CM; Hasan K; Monira S; Rahman Z; Saif-Ur-Rahman KM; Rashid MU; Zohura F; Parvin T; Islam Bhuyian MS; Mahmud MT; Li S; Perin J; Morgan C; Mustafiz M; Sack RB; Sack DA; Stine OC; Alam M
    PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006641. PubMed ID: 30052631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global dynamics of cholera models with differential infectivity.
    Shuai Z; van den Driessche P
    Math Biosci; 2011 Dec; 234(2):118-26. PubMed ID: 22001141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incorporating heterogeneity into the transmission dynamics of a waterborne disease model.
    Collins OC; Govinder KS
    J Theor Biol; 2014 Sep; 356():133-43. PubMed ID: 24769250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring the development of a household cholera-focused health literacy scale in James Town, Accra.
    Tutu RA; Gupta S; Elavarthi S; Busingye JD; Boateng JK
    J Infect Public Health; 2019; 12(1):62-69. PubMed ID: 30219358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of mass vaccination with WC/rBS cholera vaccine during an epidemic in Adjumani district, Uganda.
    Dorlencourt F; Legros D; Paquet C; Neira M; Ivanoff B; Le Saout E
    Bull World Health Organ; 1999; 77(11):949-50. PubMed ID: 10612895
    [No Abstract]   [Full Text] [Related]  

  • 29. Cost-of-illness of cholera to households and health facilities in rural Malawi.
    Ilboudo PG; Huang XX; Ngwira B; Mwanyungwe A; Mogasale V; Mengel MA; Cavailler P; Gessner BD; Le Gargasson JB
    PLoS One; 2017; 12(9):e0185041. PubMed ID: 28934285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of climate on the disease dynamics of cholera.
    Koelle K
    Clin Microbiol Infect; 2009 Jan; 15 Suppl 1():29-31. PubMed ID: 19220350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cultural influences behind cholera transmission in the Far North Region, Republic of Cameroon: a field experience and implications for operational level planning of interventions.
    Ngwa MC; Young A; Liang S; Blackburn J; Mouhaman A; Morris JG
    Pan Afr Med J; 2017; 28():311. PubMed ID: 29721141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Waterborne transmission of epidemic cholera in Trujillo, Peru: lessons for a continent at risk.
    Swerdlow DL; Mintz ED; Rodriguez M; Tejada E; Ocampo C; Espejo L; Greene KD; Saldana W; Seminario L; Tauxe RV
    Lancet; 1992 Jul; 340(8810):28-33. PubMed ID: 1351608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of case-area targeted interventions including vaccination on the control of epidemic cholera: protocol for a prospective observational study.
    Ratnayake R; Peyraud N; Ciglenecki I; Gignoux E; Lightowler M; Azman AS; Gakima P; Ouamba JP; Sagara JA; Ndombe R; Mimbu N; Ascorra A; ; Welo PO; Mukamba Musenga E; Miwanda B; Boum Y; Checchi F; Edmunds WJ; Luquero F; Porten K; Finger F
    BMJ Open; 2022 Jul; 12(7):e061206. PubMed ID: 35793924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholera.
    Behrens RH
    BMJ; 1991 May; 302(6784):1033-4. PubMed ID: 2036497
    [No Abstract]   [Full Text] [Related]  

  • 35. Reactive vaccination in the presence of disease hotspots.
    Azman AS; Lessler J
    Proc Biol Sci; 2015 Jan; 282(1798):20141341. PubMed ID: 25392464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamics analysis of a multi-strain cholera model with an imperfect vaccine.
    Safi MA; Melesse DY; Gumel AB
    Bull Math Biol; 2013 Jul; 75(7):1104-37. PubMed ID: 23636819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Quantitative Systematic Review and Meta-Analysis of the Effectiveness of Oral Cholera Vaccine as a Reactive Measure in Cholera Outbreaks.
    Schwerdtle P; Onekon CK; Recoche K
    Prehosp Disaster Med; 2018 Feb; 33(1):2-6. PubMed ID: 29317005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cholera in the world. The cholera epidemic of 1991 in Peru].
    Galdós-Tangüis H
    Gac Sanit; 1994; 8(42):139-45. PubMed ID: 7928097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk Factors for Sustained Cholera Transmission, Juba County, South Sudan, 2014.
    Ujjiga TT; Wamala JF; Mogga JJ; Othwonh TO; Mutonga D; Kone-Coulibaly A; Shaikh MA; Mpairwe AM; Abdinasir A; Abdi MA; Yoti Z; Olushayo O; Nyimol P; Lul R; Lako RL; Rumunu J
    Emerg Infect Dis; 2015 Oct; 21(10):1849-52. PubMed ID: 26402715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combating cholera epidemics by targeting reservoirs of infection and transmission routes: a review.
    Nyamogoba HD; Obala AA; Kakai R
    East Afr Med J; 2002 Mar; 79(3):150-5. PubMed ID: 12389962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.